Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma
Article 2024 en
Authors
AK
Anastasios Kyriazoglou
DP
Dionysios J. Papachristou
MM
Myrto Moutafi
Abstract
1 min read
The Hippo pathway is implicated in uLMS oncogenesis, since nuclear expression of YAP1 was detected in 17 (53.1%) of the 32 patients with immunohistochemistry and YAP1 amplification was found in 8 (25%) patients.
Caitlin B. Conboy, Germán L. Vélez‐Reyes, Barbara R. Tschida, Hsiangyu Hu, Gabriel Kaufmann, Nicholas Koes, Bryant J. Keller, Clara Alsinet, Helena Cornellà, Roser Pinyol, Juan E. Abrahante, Nuri A. Temiz, Michael A. Linden, Khalid Amin, Timothy P. Kuka, Vincent W. Keng, Josep M. Llovet, Timothy K. Starr, David A. Largaespada
Toshiro Moroishi, Hyun Woo Park, Bao‐Dong Qin, Qian Chen, Zhipeng Meng, Steven W. Plouffe, Koji Taniguchi, Fa‐Xing Yu, Michael Karin, Duojia Pan, Kun‐Liang Guan
Discussion(0)
No comments yet. Be the first to comment.